Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer
摘要
Breast cancer diagnosis primarily occurs through mammography and biopsy. Treatment options span from surgery to chemotherapy, contingent on the cancer stage. While preventative measures such as lifestyle adjustments like weight management and reduced alcohol intake can reduce cases of breast cancer, challenges persist in accessing timely screening and treatment, especially in low- and middle-income areas of the country.
MethodsThis survey engaged 59 US mothers 16 years and older with breast cancer. Administered to ensure distinct responses, it included questions covering family history, personal risk factors, menstrual cycles, pregnancies, barriers to mammograms, and strategies for enhancing healthcare support and awareness.
ResultsParticipant ages were distributed as follows: <18 (1.14%), 18-30 (38.64%), 31-40 (23.86%), 41-50 (21.59%),>50 (14.77%). A family history of ovarian or breast cancer was reported by 41 participants (69%). Identified risk factors included family history (83%), smoking (61%), alcohol consumption (44%), obesity (39%), early menarche (31%), and late menopause (22%). Awareness of recommended breast cancer screening was high, with 48 participants aware (81%). A majority (80%) believed earlier mammograms were warranted.
DiscussionParticipants underscored the significant genetic component in ovarian or breast cancer and outlined barriers to mammograms such as cost, insurance gaps, and limited awareness of financial aid. They recommended improving healthcare provider awareness, support, and access to mammogram screenings. Enhanced education on breast cancer risks and procedures was also advocated, emphasizing the need for robust support programs to assist patients in navigating their diagnosis effectively.
ConclusionThe study reveals that in this survey of mothers with breast cancer, women delay mammogram screenings due to financial concerns and fear of diagnosis. Implementing widespread medical aid initiatives can alleviate the stigma of having breast cancer, ultimately increasing screening efforts and reducing the progression and severity of breast cancer in women.